- Home
- INZY vs HYPR Comparison
INZY vs HYPR Comparison
Compare INZY & HYPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INZY
- HYPR
- Stock Information
- Founded
- INZY 2015
- HYPR 2014
- Country
- INZY United States
- HYPR United States
- Employees
- INZY N/A
- HYPR N/A
- Industry
- INZY Biotechnology: Pharmaceutical Preparations
- HYPR Medical Specialities
- Sector
- INZY Health Care
- HYPR Health Care
- Exchange
- INZY Nasdaq
- HYPR Nasdaq
- Market Cap
- INZY 64.9M
- HYPR 54.6M
- IPO Year
- INZY 2020
- HYPR N/A
- Fundamental
- Price
- INZY $0.92
- HYPR $0.70
- Analyst Decision
- INZY Strong Buy
- HYPR Strong Buy
- Analyst Count
- INZY 9
- HYPR 3
- Target Price
- INZY $17.22
- HYPR $1.33
- AVG Volume (30 Days)
- INZY 453.8K
- HYPR 462.5K
- Earning Date
- INZY 05-06-2025
- HYPR 05-12-2025
- Dividend Yield
- INZY N/A
- HYPR N/A
- EPS Growth
- INZY N/A
- HYPR N/A
- EPS
- INZY N/A
- HYPR N/A
- Revenue
- INZY N/A
- HYPR $12,890,000.00
- Revenue This Year
- INZY N/A
- HYPR $24.00
- Revenue Next Year
- INZY N/A
- HYPR $28.70
- P/E Ratio
- INZY N/A
- HYPR N/A
- Revenue Growth
- INZY N/A
- HYPR 16.84
- 52 Week Low
- INZY $0.72
- HYPR $0.58
- 52 Week High
- INZY $6.24
- HYPR $1.90
- Technical
- Relative Strength Index (RSI)
- INZY 44.29
- HYPR 43.10
- Support Level
- INZY $0.83
- HYPR $0.58
- Resistance Level
- INZY $1.08
- HYPR $0.76
- Average True Range (ATR)
- INZY 0.11
- HYPR 0.07
- MACD
- INZY 0.02
- HYPR 0.01
- Stochastic Oscillator
- INZY 55.43
- HYPR 55.45
About INZY Inozyme Pharma Inc.
Inozyme Pharma Inc is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting bone health and blood vessel function. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies. Its product candidate, INZ-701, is a soluble, recombinant, genetically engineered fusion protein that is designed to correct a defect in a pathway involving ENPP1 and ABCC6 deficiencies.
About HYPR Hyperfine Inc.
Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales which consist of sales from subscriptions of bundled devices, maintenance, and software.